Pennsylvania Names Ophelia First Virtual-First Opioid Use Disorder COE
What You Should Know: – Ophelia, a leading provider of virtual care for opioid use disorder (OUD), has been designated as a Center of Excellence
What You Should Know: – Ophelia, a leading provider of virtual care for opioid use disorder (OUD), has been designated as a Center of Excellence
Share this article Deciphera also brings ripretinib, marketed under the brand name Qinlock, to the deal. Credits: ESB Professional/Shutterstock.com Deciphera Pharmaceuticals is set to be
This story was originally published in 2022; it has since been updated. It started with a tickle in your throat. Then, it evolved into congestion,